Palmer Pharmacy Plus is an authorized DME supplier for medicare equipments and products.
Palmer Pharmacy Plus is a Pharmacy in Dallas, Texas. This pharmacy is owned and operated by Palmer Pharmacy Plus Inc. It is located at 2731 W Northwest Hwy, Suite 105, Dallas and it's customer support contact number is 214-765-9238. The authorized person of Palmer Pharmacy Plus is Pamela Ayamba Ashu who is Pharmacist/owner of the pharmacy and his contact number is 214-765-9238. Active license number of Palmer Pharmacy Plus is 23019 for Pharmacy in Texas. Palmer Pharmacy Plus accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Palmer Pharmacy Plus is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Palmer Pharmacy Plus type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Palmer Pharmacy Plus
Type:
Pharmacy
Location:
2731 W Northwest Hwy, Suite 105, Dallas, Texas, 75220-4788
Phone:
214-765-9238
Fax:
214-765-9240
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Pamela Ayamba Ashu
Position:
Pharmacist/owner
Contact Number:
214-765-9238
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1629287453
NPI Enumeration Date:
21 May, 2007
NPI Last Update On:
23 Dec, 2013
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Palmer Pharmacy Plus are as mentioned below.
Specialization
License Number
State
Status
Pharmacy
23019
Texas
Primary
Durable Medical Equipment & Medical Supplies
23019
Texas
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
146025503
Medicaid
Texas
Medicare Enrollment:
Palmer Pharmacy Plus is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
5597976779
O20100930069138
Palmer Pharmacy Plus Inc
DME SUPPLIER - PHARMACY
Products Available:
Palmer Pharmacy Plus has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Diabetic Shoes & Inserts: Custom Fabricated
Diabetic Shoes & Inserts: Prefabricated
Hospital Beds: Electric
Hospital Beds: Manual
Nebulizer Equipment & Supplies
Orthoses: Off-the-shelf
Ostomy Supplies
Walkers
Wheelchair Seating/cushions
Wheelchairs & Accessories: Standard Manual
Wheelchairs & Accessories: Standard Power
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2731 W Northwest Hwy, Suite 105 Dallas, Texas
Zip:
75220-4788
Phone Number:
214-765-9238
Fax Number:
214-765-9240
Patients can reach Palmer Pharmacy Plus at 2731 W Northwest Hwy, Suite 105, Dallas, Texas or can call on customer care at 214-765-9238.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.